Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

84 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Active, Not Recruiting

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

NCT04884035

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Local Institution - 162 Birmingham, Alabama, United States
  • Local Institution - 154 Scottsdale, Arizona, United States
  • Local Institution - 169 Duarte, California, United States
  • Local Institution - 160 Jacksonville, Florida, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

NCT05421663

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • University of Kentucky Medical Center Lexington, Kentucky, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

NCT04161248

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • University Health Network Toronto, Ontario, Canada
  • The Jewish General Hospital Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
  • Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
  • University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

FT819 in Subjects With B-cell Malignancies

NCT04629729

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Arizona Phoenix, Arizona, United States
  • UC Davis Davis, California, United States
  • Scripps Green Hospital La Jolla, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

NCT04842877

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • University Hospital Gent Ghent, Belgium
  • CH Tourelle Peltzer Verviers, Belgium
  • CHU Mont-Godinne Yvoir, Belgium
View all 22 locations
View Trial Details

Related conditions